| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.70B | 1.47B | 1.42B | 1.87B | 1.60B |
| Gross Profit | 526.24M | 455.48M | 476.36M | 637.30M | 479.22M |
| EBITDA | 248.91M | 210.98M | 278.82M | 354.76M | 262.86M |
| Net Income | 118.47M | 57.07M | 117.95M | 195.39M | 128.08M |
Balance Sheet | |||||
| Total Assets | 2.00B | 1.94B | 1.79B | 1.96B | 1.67B |
| Cash, Cash Equivalents and Short-Term Investments | 178.95M | 214.72M | 331.02M | 275.28M | 222.80M |
| Total Debt | 188.99M | 259.77M | 215.47M | 310.77M | 317.75M |
| Total Liabilities | 713.72M | 765.58M | 625.42M | 889.33M | 767.40M |
| Stockholders Equity | 1.21B | 1.12B | 1.11B | 1.03B | 876.91M |
Cash Flow | |||||
| Free Cash Flow | 115.70M | -58.13M | 113.80M | 167.91M | 66.22M |
| Operating Cash Flow | 190.25M | 152.66M | 349.29M | 245.98M | 88.16M |
| Investing Cash Flow | -78.64M | -254.90M | -143.23M | -104.30M | -47.11M |
| Financing Cash Flow | -126.42M | -34.80M | -132.93M | -86.34M | -63.14M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | HK$821.12M | 7.06 | 16.16% | 4.60% | 12.73% | 9.25% | |
74 Outperform | HK$12.68B | 11.59 | 9.07% | 10.16% | 1.53% | -21.76% | |
72 Outperform | HK$690.95M | 4.60 | 9.96% | 6.35% | 15.37% | 107.52% | |
66 Neutral | HK$23.73B | 8.62 | 9.61% | 7.69% | -1.93% | -1.36% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
49 Neutral | HK$317.94M | -12.78 | -2.53% | 4.15% | 2.32% | -88.07% | |
46 Neutral | HK$239.79M | -1.27 | -20.20% | ― | -30.43% | -97.13% |